Assessing the evidence for remodelling of the airway in asthma

Pulmonary Pharmacology and Therapeutics

Volumn 14, Issue 3, 2001, Pages 229-247

  Wilson, John W ^a   Bamford, Tiffany L ^b  

^a ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Asthma; Epidemiology; Growth factors; Immunopathology; Inflammation

Indexed keywords

COLLAGEN; CYTOKINE; GROWTH FACTOR;

AIRWAY OBSTRUCTION; ASTHMA; BRONCHODILATATION; BRONCHUS MUCOSA; CELL INFILTRATION; CONFERENCE PAPER; EOSINOPHIL; FIBROBLAST; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAST CELL; MUCUS GLAND; MUSCLE HYPERTROPHY; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

EID: 0034936034     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.2001.0294     Document Type: Review

References (217)

1. Comparison of three definitions of asthma: A longitudinal perspective
2. Measuring persistent cough in children in epidemiological studies: Development of a questionnaire and assessment of prevalence in two countries
3. International Study of Asthma and Allergies in Childhood (ISAAC): Rationale and methods
4. Relation between respiratory symptoms, pulmonary function and peak flow variability in adults
5. Effects of asthma on pulmonary function in children. A longitudinal population-based study
6. Longitudinal effects of passive smoking on pulmonary function in New Zealand children
7. Large lungs after childhood asthma: A consequences of enlarged airspaces
8. Prevalence, natural history, and relationship of wheezy bronchitis and asthma in children. An epidemiological study
9. Childhood asthma and adult lung function
10. Childhood asthma in adult life: A further study at 28 years of age
11. Outcome of childhood asthma in mid-adult life
12. Childhood asthma and lung function in mid-adult life
13. Bronchial hyperresponsiveness, atopy, airway inflammation, and asthma
14. Adult patients may outgrow their asthma: A 25-year follow-up study
15. Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodeling of the airways in asthma
16. Bronchial mucosal manifestations of atopy: A comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls
17. Clinical control and histopathologic outcome of asthma when using airway hypperresponsiveness as an additional guide to long-term treatment
18. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma
19. Effect of early vs late intervention with inhaled corticosteroids in asthma
20. Factors in childhood as predictors of asthma in adult life
21. The influence of increased bronchial responsiveness, atopy, and serum IgE on decline in FEV1. A longitudinal study in the elderly
22. Usefulness of repeated measurements of bronchial hyperresponsiveness for the diagnosis of occupational asthma
23. The pathology of asthma, with special reference to the bronchial mucosa
24. Mucosal inflammation in asthma
25. Lymphocyte activation in bronchoalveolar lavage and peripheral blood in atopic asthma
26. Subepithelial fibrosis in the bronchi of asthmatics
27. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway
28. Airway remodelling in cystic fibrosis
29. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines
30. Predominant TH2-Like bronchoalveolar T-lymphocyte population in atopic asthma
31. Characterization of the human cysteinyl leukotriene 2 receptor
32. Airways remodelling in asthma: No doubt, no more?
33. Inflammation and cytokines in airway wall remodelling
34. Airway wall remodelling in asthma
35. Human airway narrowing measured using high resolution computed tomography
36. Relationship between airway wall thickness and airway hyperresponsiveness
37. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry
38. Bronchial blood vessel dimensions in asthma
39. Small airways dimensions in asthma and in chronic obstructive pulmonary disease
40. Increased vascularity of the bronchial mucosa in mild asthma
41. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study
42. The lack of distensibility of asthmatic airways
43. Mechanics of airway narrowing
44. The mechanics of airway narrowing in asthma
45. Rate of decline of lung function in subjects with asthma
46. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use
47. The shedding of the mucosa of the bronchial tree in asthma
48. Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients. Relationship to atopic status, symptoms, and level of airway hyperresponsiveness
49. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack
50. Asthma deaths confounded by substance abuse. An assessment of fatal asthma
51. Functional significance of increased airway smooth muscle in asthma and COPD
52. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease
53. Peripheral blood eosinophil counts and bronchial responsiveness
54. Changes in T-lymphocyte subpopulations after antigenic bronchial provocation in asthmatics
55. CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status
56. Association of asthma with serum IgE levels and skin-test reactivity to allergens
57. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy
58. Proinflammatory cytokines in acute asthma
59. Summary and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in asthmatics
60. Investigative use of bronchoscopy, lavage and bronchial biopsies in asthma and other airways diseases
61. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects
62. Bronchoalveolar mast cells in extrinsic asthma: A mechanism for the initiation of antigen specific bronchoconstriction
63. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness
64. Mast cell and histamine content of human bronchoalveolar lavage fluid
65. Cellular and protein changes in bronchial lavage fluid after late asthmatic reaction in patients with red cedar asthma
66. Bronchoalveolar lavage in the asthmatic
67. Cellular events in the bronchi in mild asthma and after bronchial provocation
68. Lymphocyte subsets in bronchoalveolar lavage fluid obtained from stable asthmatics, and their correlations with bronchial responsiveness
69. Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma
70. Bronchial biopsy in chronic bronchitis and asthma
71. Damage of the airway epithelium and bronchial reactivity in patients with asthma
72. The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma
73. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma
74. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma
75. Death from bronchial asthma
76. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema
77. Bronchial biopsy in chronic bronchitis and asthma
78. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma
79. Abnormalities in airway smooth muscle in fatal asthma
80. Bronchial asthma: Mechanisms and therapeutics
81. Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity
82. The site of disruption of the bronchial epithelium in asthmatic and non-asthmatic subjects
83. Structural characterization of bronchial mucosal biopsies from healthy volunteers: A light and electron microscopical study
84. Morphological integrity of the bronchial epithelium in mild asthma
85. The structure of large and small airways in nonfatal and fatal asthma
86. Asthma as an axon reflex
87. Cytokines as mediators of chronic asthma
88. Biology of airway epithelial cells
89. Bronchial epithelial cells of patients with asthma release chemoattractant factors for T lymphocytes
90. Interleukin-1 binds to specific receptors on human bronchial epithelial cells and upregulates granulocyte/macrophage colony-stimulating factor synthesis and release
91. Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha
92. Inhibition of interleukin-8 expression by dexamethasone in human cultured airway epithelial cells
93. Effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial epithelial cells in vitro
94. Induction of ICAM-1 expression on human airway epithelial cells by inflammatory cytokines: Effects on neutrophil-epithelial cell adhesion
95. Physical determinants of bronchial mucosal folding
96. Mechanical stress stimulates aortic endothelial cells to proliferate
97. Lung immunopathology in cases of sudden asthma death
98. Cyclosporine A reduces T lymphocyte activity and improves airway hyperresponsiveness in corticosteroid-dependent chronic severe asthma
99. T lymphocyte activation in acute severe asthma
100. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage
101. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity
102. Cytokines. 3 Cytokines in asthma
103. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline
104. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma
105. Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia
106. The T cell and the airways fibrotic response in asthma
107. Human mast cells and basophils - Structure, function, pharmacology, and biochemistry
108. The mast cell in asthma
109. Mast cells in bronchoalveolar lumen of patients with bronchial asthma
110. Cytokines 1 - Overview
111. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils
112. Mast cells as a source of multifunctional cytokines
113. Two types of human mast cells that have distinct neutral protease compositions
114. Mast cells in atopic dermatitis
115. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells
116. A preliminary study of long-term treatment with interferon gamma-lb and low-dose prednisolone in patients with idiopathic pulmonary fibrosis
117. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa?
118. T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis
119. The local and constitutional pathology of bronchial asthma
120. The eosinophil and bronchial asthma: Current understanding
121. Eosinophilic inflammation in asthma
122. The immunobiology of eosinophils
123. Stimulation of proliferation, differentiation, and function of human cells by primate interleukin 3
124. The colony stimulating factors. Discovery, development, and clinical applications
125. Role of IgE receptors in effector function of human eosinophils
126. Selectivity of mediators released by eosinophils
127. Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils
128. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival
129. Recombinant human interleukin 5 is a selective activator of human eosinophil function
130. The eosinophil as a mediator of damage to respiratory epithelium: A model for bronchial hyperreactivity
131. Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils
132. Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease
133. Human eosinophils synthesize and secrete interleukin-6, in vitro
134. Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore
135. Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils
136. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness
137. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma
138. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs
139. CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea
140. Effect of dexamethasone and cyclosporin A on allergen-induced airway hyperresponsiveness and inflammatory cell responses in sensitized Brown-Norway rats
141. Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta I gene (TGF beta 1)
142. Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation
143. Mechanisms of endothelial growth control
144. Current concepts: Immunology. Monocytes and macrophages
145. The monocyte in cellular immunity
146. The concept of the activated macrophage
147. Activation of human macrophages. Comparison of other cytokines with interferon-gamma
148. The alveolar macrophage
149. Immunoglobulin E-dependent stimulation of human alveolar macrophages: Significance in type 1 hypersensitivity
150. Structure and function of Fc receptors for IgE on lymphocytes, monocytes, and macrophages
151. Secretory products of macrophages
152. Synthesis of leukotriene B4, and prostanoids by human alveolar macrophages: Analysis by gas chromatography/mass spectrometry
153. The contribution of alveolar macrophages to hyperreactive airway disease
154. Eicosanoids and lung inflammation
155. Effects of arachidonic acid, monohydroxyeicosatetraenoic acid and prostaglandins on the release of mucous glycoproteins from human airways in vitro
156. Leukotrienes are potent constrictors of human bronchi
157. Inflammatory mediators and asthma
158. Platelet-activating factor (PAF-acether) induced leukotriene C4 formation and luminol dependent chemiluminescence by human eosinophils
159. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man
160. The bronchoconstrictor properties of platelet-activating factor in humans
161. Interleukin-6 and its receptor in immune regulation
162. Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells
163. IFN beta 2/BSF2/IL-6 is the monocyte-derived HSF that regulates receptor-specific acute phase gene regulation in hepatocytes
164. Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue
165. Colonic pericrypt sheath cells: Characterisation of cell type with new monoclonal antibody
166. Myofibroblasts and subepithelial fibrosis in bronchial asthma
167. Mast cell histamine, a local mitogen acting via H2-receptors in nearby tissue cells
168. Mast cells and tumors. The specific enhancement of tumor proliferation in vitro
169. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores
170. Eosinophils stimulate fibroblast DNA synthesis
171. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF
172. Endothelin stimulates phospholipase C, Na +/H + exchange, c-fos expression, and mitogenesis in rat mesangial cells
173. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins
174. Fibrogenic cytokines: The role of immune mediators in the development of scar tissue
175. Fibrogenic cytokines in airway fibrosis
176. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation
177. Heterogeneity of human mast cells based on cytokine content
178. Interleukin-1 can inhibit interferon-beta synthesis and its antiviral action: Comparison with tumor necrosis factor
179. In situ injury-induced release of basic-fibroblast growth factor from corneal epithelial cells
180. Production and action of insulin-like growth factor I/somatomedin C in primary cultures of fetal lung fibroblasts
181. Stimulation of collagen formation by insulin and insulin-like growth factor I in cultures of human lung fibroblasts
182. Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma
183. Endobronchial allergen challenge in asthma. Demonstration of cellular source of granulocyte macrophage colony-stimulating factor by in situ hybridization
184. TNF alpha mRNA expression in allergic inflammation
185. Recent advances in understanding the pathogenesis of asthma and its clinical implications
186. Mast cells
187. The bronchial basement membrane in asthma
188. Alterations in the structure of bronchial basement membrane in relation to textural changes of the bronchial mucosa
189. Airways remodeling is a distinctive feature of asthma and is related to severity of disease
190. Cell matrix in response to airway injury
191. Scar collagen deposition in the airways of allografts of lung transplant recipients
192. Subepithelial and submucosal collagen in fatal asthma
193. Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours
194. Effect of histamine on tracheal mucosal perfusion, water content and airway smooth muscle in sheep
195. Inhibition of bradykinin induced macromolecular leakage from post-capillary venules by a beta2-adrenoreceptor stimulant, terbutaline
196. Effects of inflammatory and other mediators on airway vascular beds
197. Dose-related effects of pharmacological mediators on tracheal vascular resistance in dogs
198. Acute microvascular effects of PAF-acether, as studied by intravital microscopy
199. Neurogenic inflammation in the respiratory tract: Actions of sensory nerve mediators on blood vessels and epithelium of the airway mucosa
200. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
201. Effects of increased bronchial blood flow on airway morphometry, resistance, and reactivity
202. Is asthma a vascular disorder?
203. Airway distensibility in healthy and asthmatic subjects: Effect of lung volume history
204. The bronchial vasculature in asthma
205. Regulation of airway wall remodeling: Prospects for the development of novel antiasthma drugs
206. Beta 2-adrenoceptor agonist-mediated inhibition of human airway smooth muscle cell proliferation: Importance of the duration of beta 2-adrenoceptor stimulation
207. Bronchial hyporesponsiveness
208. Airway remodelling takes place in asthma - What are the clinical implications?
209. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma
210. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid
211. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma
212. Cellular infiltration of the airways in asthma of varying severity
213. Airway structure and inflammatory cells in fatal attacks of asthma
214. The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics
215. Comparative morphology of the airways in asthma and chronic obstructive pulmonary disease
216. Muscle and mucous gland size in the major bronchi of patients with chronic bronchitis, asthma, and asthmatic bronchitis
217. The pathology of bronchial asthma